This meta-analysis is novel work as there were only a few studies conducted in the Asian population to compare the safety and efficacy of currently available long-acting insulin (insulin degludec and glargine) in type 2 diabetes mellitus patients. Here, INS is linked to type 2 diabetes mellitus.